FDA Clearance Tracker · P110008-S008
coflex® Interlaminar Technology
Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Apr 25, 2018
Approved
Time to decision
303 days
Received Jun 26, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P110008-S008
- Device name
- coflex® Interlaminar Technology
- Applicant
- Companion Spine France
- Applicant location
- Merignac Gironde
- Received
- Jun 26, 2017
- Decided
- Apr 25, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P110008
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
Approval for introducing a set of disposable instruments for the coflex® and for Otto Klumpp to manufacture these disposable instruments at Burgstraße 18, 72336, Balingen-Ostdorf, Germany.
Source documents
Other decisions for Companion Spine France
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253118 · Decided Dec 16, 2025 · 83 days after receipt
Device type: Manual Instruments Designed For Use With Non-Fusion Spinous Process Spacer Devices (QLR) · Orthopedic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.